Synthesis and antitumor activity of peptide-paclitaxel conjugates

Journal of Peptide Science

Volumn 13, Issue 10, 2007, Pages 662-671

  Papas, Serafim ^a   Akoumianaki, Tonia ^b   Kalogiros, Christos ^a   Hadjiarapoglou, Lazaros ^a   Theodoropoulos, Panayiotis A ^b   Tsikaris, Vassilios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Artificial carriers; Paclitaxel antitumor agents; Paclitaxel derivatives; Paclitaxel ESI MS; Taxol derivatives; Thioether bond

Indexed keywords

2' BROMOACETYLPACLITAXEL; 2' CHLOROACETYLPACLITAXEL; 2' IODOACETYLPACLITAXEL; ANTINEOPLASTIC AGENT; DRUG CARRIER; PACLITAXEL; PACLITAXEL DERIVATIVE; PEPTIDE DERIVATIVE; POLYPEPTIDE; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; COVALENT BOND; DRUG ACETYLATION; DRUG ACTIVITY; DRUG CONJUGATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; OLIGOPEPTIDES; PACLITAXEL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 35348833548     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.899     Document Type: Article

References (33)

1. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971; 93: 2325-2327.
2. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N. Engl. J. Med. 1995; 332: 1004-1014.
3. Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer 1999; 83: 151-156.
4. Theodoropoulos PA, Polioudaki H, Kostaki O, Derdas SP, Georgoulias V, Dargemont C, Georgatos SD. Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus. Cancer Res. 1999; 59: 4625-4633.
5. Nicolaou KC, Riemer C, Kerr MA, Rideout D, Wrasidlo W. Design, synthesis and biological activity of protaxols. Nature 1993; 364: 464-466.
6. Nuijen B, Bouma M, Schellens JHM, Beijnen JH. Progress in the development of alternative pharmaceutical formulations of taxanes. Invest. New Drugs 2001; 19: 143-153.
7. Gelderblom H, Verweij J, Nooter K, Sparreboom V. Cremophor EL. the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001; 37: 1590-1598.
8. Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud JB, Couladouros EA, Paulvannan K, Sorensen EJ. Total synthesis of taxol. Nature 1994; 367: 630-634.
9. Denis JN, Correa A, Greene AE. An improved synthesis of the taxol side chain and of RP 56976. J. Org. Chem. 1990; 55: 1957-1959.
10. Danishefsky SJ, Masters JJ, Young WB, Link JT, Snyder LB, Magee TV, Jung DK, Isaacs RCA, Bornmann WG, Alaimo CA, Coburn CA, Di Grandi MJ. Total synthesis of baccatin III and taxol. J. Am+ Chem. Soc. 1996; 118: :2843-2859.
11. Kingston DGI, Chaudhary AG, Gunatilaka AAL, Middleton ML. Synthesis of taxol from baccatin III via an oxazoline intermediate. Tetrahedron Lett. 1994; 35: 4483-4484.
12. Ojima I, Habus I, Zhao M. Efficient and practical asymmetric synthesis of the taxol C-13 side chain, N-benzoyl-(2R,3S)-3-phenylisoserine, and its analogs via chiral 3-hydroxy-4-aryl-beta-lactams through chiral ester enolate-imine cyclocondensation. J. Org. Chem. 1991; 56: 1681-1683.
13. Brown S, Jordan AM, Lawrence NJ, Pritchard RG, McGown AT. A convenient synthesis of the paclitaxel side-chain via a diastereoselective Staudinger reaction. Tetrahedron Lett. 1998; 39: 3559-3562.
14. Lee JW, Fuchs PL. Reduction of azides to primary amines in substrates bearing labile ester functionality. Synthesis of a PEG-solubilized, "Y"-shaped iminodiacetic acid reagent for preparation of folate-tethered drugs. Org. Lett. 1999; 1: 179-182.
15. Ueda Y, Wong H, Matiskella JD, Mikkikineni AB, Farina V, Fairchild C, Rose WC, Mamber SW, Long BH, Kerns EH, Casazza AM, Vyas DM. Synthesis and antitumor evaluation of 2′-oxycarbonylpaclitaxels (paclitaxel-2′-carbonates). Bioorg. Med. Chem. Lett. 1994; 4: 1861-1864.
16. Niethammer A, Gaedicke G, Lode HN, Wrasidlo W. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility. Bioconjugate Chem. 2001; 12: 414-420.
17. Lee JW, Lu JY, Low PS, Fuchs PL. Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics. Bioorg. Med. Chem. 2002; 10: 2397-2414.
18. Deutsch HM, Glinski JA, Hernandez M, Haugwitz RD, Narayanan VL, Suffness M, Zalkow LH. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 1989; 32: 788-792.
19. Kirschberg TA, VanDeusen CL, Rothbard JB, Yang M, Wender PA. Arginine-based molecular transporters: the synthesis and chemical m evaluation of releasable taxol-transporter conjugates. Org. Lett. 2003; 5: 3459-3462.
20. Lee JW, Lu JY, Low PS, Fuchs PL. Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics. Bioorg. Med. Chem. 2002; 10: 2397-2414.
21. Chen X, Plasencia C, Hou Y, Neamati N. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J. Med. Chem. 2005; 48: 1098-1106.
22. Wang S, Zhelev NZ, Duff S, Fischer PM. Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin. Bioorg. Med. Chem. Lett. 2006; 16: 2628-2631.
23. Skwarczynski M, Hayashi Y, Kiso Y. Paclitaxel prodrugs: toward smarter delivery of anticancer agents. J. Med. Chem. 2006; 49: 7253-7269.
24. α-tetrasubstitution). Biopolymers (Pept. Sci.) 2001; 60: 396-419.
25. n) for multiple anchoring of antigenic peptides: application to the acetylcholine receptor (AChR) main immunogenic region. Int. J. Biol. Macromol. 1996; 19: 195-205.
26. Tsikaris V, Sakarellos C, Cung MT, Marraud M, Sakarellos-Daitsiotis M, Concept and design of a new class of sequential oligopeptide carriers (SOC) for covalent attachment of multiple antigenic peptides. Biopolymers 1996; 38: 291-293.
27. Papas S, Strongylis C, Tsikaris V. Synthetic approaches for total chemical synthesis of proteins and protein-like macromolecules of branched architecture. Curr. Org. Chem. 2006; 10: 1727-1744.
28. Jones J. Abbreviations and symbols in peptide science: a revised guide and commentary. J. Pept. Sci. 2006; 12: 1-12.
29. Stewart JM, Young JD. Solid Phase Peptide Synthesis. 2nd edn. Pierce Chemical Company: Illinois, 1984; 43.
30. Stathopoulos P, Papas S, Tsikaris V. C-terminal N-alkylated peptide amides resulting from the linker decomposition of the Rink amide resin: a new cleavage mixture prevents their formation. J. Pept. Sci. 2006; 12: 227-232.
31. Poon GK, Wade J, Bloomer J, Clarke SE, Maltas J. Rapid screening of taxol metabolites in human microsomes by liquid chromatography/ electrospay ionization-mass spectrometry. Rapid Commun. Mass Spectrom. 1996; 10: 1165-1168.
32. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996; 56: 816-825.
33. Michalakis J, Georgatos SD, Romanos J, Koutala H, Georgoulias V, Tsiftsis D, Theodoropoulos PA. Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells. Cancer Chemother. Pharmacol. 2005; 56: 615-622.